UBS AM’s National Healthcare NHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.4M | Sell |
25,548
-770
| -3% | -$141K | ﹤0.01% | 1570 |
|
|
2026
Q1 | $4.2M | Buy |
26,318
+198
| +0.8% | +$30.4K | ﹤0.01% | 1656 |
|
|
2025
Q4 | $3.58M | Sell |
26,120
-292
| -1% | -$37.7K | ﹤0.01% | 1625 |
|
|
2025
Q3 | $3.21M | Sell |
26,412
-15,511
| -37% | -$1.67M | ﹤0.01% | 1567 |
|
|
2025
Q2 | $4.49M | Buy |
41,923
+11,677
| +39% | +$1.17M | ﹤0.01% | 1765 |
|
|
2025
Q1 | $2.81M | Buy |
30,246
+4,628
| +18% | +$448K | ﹤0.01% | 1838 |
|
|
2024
Q4 | $2.76M | Buy |
25,618
+2,010
| +9% | +$245K | ﹤0.01% | 1888 |
|
|
2024
Q3 | $2.97M | Sell |
23,608
-4,216
| -15% | -$530K | ﹤0.01% | 1824 |
|
|
2024
Q2 | $3.02M | Buy |
27,824
+11,732
| +73% | +$1.14M | ﹤0.01% | 1776 |
|
|
2024
Q1 | $1.52M | Buy |
16,092
+2,844
| +21% | +$269K | ﹤0.01% | 1809 |
|
|
2023
Q4 | $1.22M | Hold |
13,248
| – | – | ﹤0.01% | 1920 |
|
|
2023
Q3 | $848K | Sell |
13,248
-3,160
| -19% | -$202K | ﹤0.01% | 2042 |
|
|
2023
Q2 | $953K | Hold |
16,408
| – | – | ﹤0.01% | 2028 |
|
|
2023
Q1 | $953K | Buy |
16,408
+1,282
| +8% | +$73.7K | ﹤0.01% | 2028 |
|
|
2022
Q4 | $900K | Buy |
15,126
+1,466
| +11% | +$88.9K | ﹤0.01% | 1899 |
|
|
2022
Q3 | $865K | Sell |
13,660
-708
| -5% | -$49.2K | ﹤0.01% | 2053 |
|
|
2022
Q2 | $1M | Buy |
14,368
+763
| +6% | +$53.4K | ﹤0.01% | 1959 |
|
|
2022
Q1 | $955K | Buy |
13,605
+1,350
| +11% | +$90.8K | ﹤0.01% | 2171 |
|
|
2021
Q4 | $833K | Hold |
12,255
| – | – | ﹤0.01% | 2304 |
|
|
2021
Q3 | $858K | Buy |
12,255
+2,397
| +24% | +$174K | ﹤0.01% | 2252 |
|
|
2021
Q2 | $689K | Buy |
9,858
+843
| +9% | +$61.3K | ﹤0.01% | 2404 |
|
|
2021
Q1 | $702K | Hold |
9,015
| – | – | ﹤0.01% | 2252 |
|
|
2020
Q4 | $599K | Hold |
9,015
| – | – | ﹤0.01% | 2231 |
|
|
2020
Q3 | $562K | Hold |
9,015
| – | – | ﹤0.01% | 2089 |
|
|
2020
Q2 | $572K | Buy |
9,015
+1,337
| +17% | +$89.6K | ﹤0.01% | 2061 |
|
|
2020
Q1 | $551K | Sell |
7,678
-262
| -3% | -$20.7K | ﹤0.01% | 1942 |
|
|
2019
Q4 | $686K | Buy |
7,940
+44
| +0.6% | +$3.68K | ﹤0.01% | 2101 |
|
|
2019
Q3 | $646K | Buy |
7,896
+5,195
| +192% | +$430K | ﹤0.01% | 2162 |
|
|
2019
Q2 | $219K | Buy |
+2,701
| New | +$208K | ﹤0.01% | 2515 |
|
|
2016
Q4 | – | Sell |
-3,100
| Closed | -$205K | – | 2601 |
|
|
2016
Q3 | $205K | Hold |
3,100
| – | – | ﹤0.01% | 2456 |
|
|
2016
Q2 | $201K | Buy |
+3,100
| New | +$197K | ﹤0.01% | 2444 |
|
Other funds holding NHC
MSIIA
UBS AM's NHC Position: Q2 2026 in Review
UBS AM reduced its National Healthcare (NHC) stake by 2.9% in Q2 2026, selling an estimated $141K and leaving 25,548 shares worth $5.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1570.
UBS AM first reported a position in NHC in Q2 2016 and has held it in 31 quarters since. 249 funds tracked by Wall St. Rank hold NHC as of Q2 2026.
- UBS AM held 25,548 shares of National Healthcare worth $5.4M as of Q2 2026.
- UBS AM sold 770 National Healthcare shares in Q2 2026, an estimated $141K.
- National Healthcare made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1570 holding.
- UBS AM first reported a position in National Healthcare in Q2 2016 and has held it in 31 quarters since.
- 249 funds tracked by Wall St. Rank held National Healthcare as of Q2 2026.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.